After halting a CYP3A4 inducer, because the effects from the inducer decline, the fentanyl plasma concentration will raise which could boost or prolong equally the therapeutic and adverse effects.For oral drugs where reductions in bioavailability may well cause clinically significant effects on its basic safety or efficacy, separate administration